• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOMET FRANCE S.A.R.L. OPTIPAC 80 REFOBACIN BONE CEMENT R-3; BONE CEMENT, ANTIBIOTICS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOMET FRANCE S.A.R.L. OPTIPAC 80 REFOBACIN BONE CEMENT R-3; BONE CEMENT, ANTIBIOTICS Back to Search Results
Catalog Number 4712500398-3
Device Problem Improper Chemical Reaction (2952)
Patient Problems No Consequences Or Impact To Patient (2199); No Information (3190)
Event Date 08/04/2020
Event Type  malfunction  
Manufacturer Narrative
(b)(4).Report source, foreign - event occurred in (b)(6).The investigation is in progress.Once the investigation has been completed, a follow-up mdr will be submitted.If any further information is found which would change or alter any conclusions or information, a supplemental will be filed accordingly.
 
Event Description
It was reported that the cement did not mix well.The paste was watery after mixing.No known adverse event has been reported for now.
 
Event Description
It was reported that the cement did not mix well.The paste was watery after mixing.No adverse events have been reported as a result of the malfunction.
 
Manufacturer Narrative
(b)(4).This follow-up report is being submitted to relay additional and corrected information.The following section has been updated: b4, e1, e2, e3, g4, g7, h2, h3, h6 and h10.The following section has been corrected: b3, b5.Received pictures show the patient labels: the ref/batch combination of the product involved in the complaint can be confirmed.Also,pictures of the optipac show that the cement has been mixed, the plunger is up, the mixing rod broken and the nozzle assembled.The paste seems homogeneous, no alter consistency can be seen.However, the cement paste seems to be white (and not green) which could indicate that the mixing was not completed.Also, it can be observed some empty space in the cylinder, which means that the cement was not pressurized enough.Indeed, the plunger is not up enough.The product analysis can't be performed as the product was not returned.A retain sample of batch az05dk0806 has been tested in the laboratory under standardized conditions (23°c; rel.Humid >=40 %).No unusual behavior during mixing, handling or setting.The reported behavior of the cement cannot be reproduced.The device manufacturing quality record indicate that the released product met all requirements to perform as intended.A complaint extract was done regarding cement paste consistency: 1 complaint (1 product, this one included, has been recorded on optipac 80 refobacin bone cement r-3, reference (b)(4), from (b)(6) 2017 to (b)(6) 2021.1 complaint (1 product), this one included, has been recorded on optipac 80 refobacin bone cement r-3, reference (b)(4), batch az05dk0806.According to available data, root cause of the event was unable to be determined.A summary of the investigation was sent to the complainant conveying zimmer biomet conclusions.If any further information is found which would change or alter any conclusions or information, a supplemental will be filed accordingly.Zimmer biomet will continue to monitor for trends.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OPTIPAC 80 REFOBACIN BONE CEMENT R-3
Type of Device
BONE CEMENT, ANTIBIOTICS
Manufacturer (Section D)
BIOMET FRANCE S.A.R.L.
plateau de lautagne bp75
valence cedex 26903
FR  26903
MDR Report Key10435794
MDR Text Key205142632
Report Number3006946279-2020-00154
Device Sequence Number1
Product Code MBB
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 02/02/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date07/31/2021
Device Catalogue Number4712500398-3
Device Lot NumberAZ05DK0806
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 08/04/2020
Initial Date FDA Received08/21/2020
Supplement Dates Manufacturer Received02/02/2021
Supplement Dates FDA Received02/03/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-